Eli Lilly and Biogen Announce Major Biotech Acquisitions, Boosting Market Confidence
Eli Lilly and Biogen are acquiring Centessa Pharma and Apellis Pharma, respectively, propelling biotech stocks upward. These major deals underscore ongoing industry consolidation amidst mixed approval signals and shifting market dynamics.
· 64d ago
